9TD.F ARCTIC BIOSCIENCE NK -10
- Market cap
- -
- P/E
- -
- P/B
- 0.39x
- ROE
- -23.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 9TD.F undervalued?
Graham numberThe Graham number of ARCTIC BIOSCIENCE NK -10 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ARCTIC BIOSCIENCE NK -10 fundamental analysis
No fundamental analysis for ARCTIC BIOSCIENCE NK -10 yet.
ARCTIC BIOSCIENCE NK -10 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
ARCTIC BIOSCIENCE NK -10 financial statements
ARCTIC BIOSCIENCE NK -10 annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 21.5M | 34.3M | 33.8M | 43.5M | 40.1M |
| Gross Profit | 5.16M | 11.6M | 9.77M | 11.9M | 11.0M |
| Operating Income | -40.6M | -37.4M | -48.6M | -47.8M | -33.4M |
| EBITDA | - | -30.3M | -39.1M | -39.6M | -26.8M |
| Net Income | -42.6M | -34.0M | -45.5M | -47.9M | -41.0M |
| EPS | -1.75 | -1.40 | -1.79 | -1.89 | -1.52 |
| Balance Sheet | |||||
| Total Assets | 341M | 328M | 300M | 280M | 285M |
| Total Liabilities | 20.9M | 40.4M | 41.7M | 69.0M | 111M |
| Shareholders' Equity | 321M | 287M | 259M | 211M | 173M |
| Cash & Short-term Investments | 225M | 143M | 78.5M | 2.16M | 218K |
| Cash Flow | |||||
| Operating Cash Flow | -39.5M | -25.4M | -30.4M | -45.4M | -22.7M |
| Capital Expenditure | 36.5M | 58.6M | 34.7M | 50.8M | 22.7M |
| Free Cash Flow | -76.0M | -84.0M | -65.1M | -96.2M | -45.4M |
| Ratios | |||||
| ROE | -13.3% | -11.8% | -17.6% | -22.7% | -23.6% |
| ROA | -12.5% | -10.4% | -15.2% | -17.1% | -14.4% |
| Net Profit Margin | -197.9% | -99.3% | -134.9% | -110.2% | -102.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ARCTIC BIOSCIENCE NK -10 dividends
ARCTIC BIOSCIENCE NK -10 has not paid dividends in the last 5 fiscal years.
Who owns ARCTIC BIOSCIENCE NK -10
Ownership data of ARCTIC BIOSCIENCE NK -10 is not available yet.
ARCTIC BIOSCIENCE NK -10 company profile
- Company name
- ARCTIC BIOSCIENCE NK -10
- Ticker
- 9TD.F
- ISIN
- NO0010859580
- Exchange
- Frankfurt Exchange
- Sector
- -
- Industry
- -
- Fiscal year end
- December
- Address
- Website
- -